Evogene Ltd. (EVGN)
Automate Your Wheel Strategy on EVGN
With Tiblio's Option Bot, you can configure your own wheel strategy including EVGN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EVGN
- Rev/Share 1.2524
- Book/Share 2.1835
- PB -5.9947
- Debt/Equity -8.8725
- CurrentRatio 1.1548
- ROIC -0.7079
- MktCap 8540381.0
- FreeCF/Share -2.9911
- PFCF -0.4202
- PE -0.5277
- Debt/Assets 0.3229
- DivYield 0
- ROE -11.8554
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Evogene Ltd. (NASDAQ:EVGN ) Q1 2025 Earnings Conference Call May 21, 2025 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Operator Welcome to Evogene's First Quarter 2025 Results Conference Call.
Read More
Evogene Schedules First Quarter 2025 Financial Results Release
Published: May 08, 2025 by: PRNewsWire
Sentiment: Neutral
Zoom conference call scheduled for May 21, 2025, 9:00 AM ET REHOVOT, Israel , May 8, 2025 /PRNewswire/ -- May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Wednesday, May 21, 2025.
Read More
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
Published: April 21, 2025 by: PRNewsWire
Sentiment: Neutral
Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products REHOVOT, Israel , April 21, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing of a definitive agreement under which ICL, will acquire the majority of activity of Evogene's subsidiary, Lavie Bio Ltd.
Read More
Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript
Published: March 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Evogene Ltd. (NASDAQ:EVGN ) Q4 2024 Earnings Conference Call March 6, 2025 9:00 AM ET Company Participants Ofer Haviv - President and CEO Nir Nimrodi - Chairperson of the Board Yaron Eldad - Chief Financial Officer Operator Welcome to Evogene's Fourth Quarter Results Conference Call.
Read More
Evogene Schedules Fourth Quarter 2024 Financial Results Release
Published: February 20, 2025 by: PRNewsWire
Sentiment: Neutral
Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel , Feb. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025.
Read More
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease
Published: February 13, 2025 by: PRNewsWire
Sentiment: Neutral
Initial fungicidally active compounds already discovered REHOVOT, Israel , Feb. 13, 2025 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd.
Read More
About Evogene Ltd. (EVGN)
- IPO Date 2010-10-15
- Website https://www.evogene.com
- Industry Biotechnology
- CEO Ofer Haviv CPA
- Employees 117